← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 15, 2018Last known activity
Nov 1, 2020
Timeline
2010s
- Aug 1, 2014
NeuroActiva— Founded
Drugs by trial phase (5 distinct, 4 trials)
Phase 3 (5 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Cognition Disorders
- Cognitive Dysfunction
- Communicable Diseases
- Coronavirus Infections
- Dementia
- Dementia, Vascular
- Disease
- Infections
- Lewy Body Disease
- Nerve Degeneration
- Neurocognitive Disorders
- Neurodegenerative Diseases
- Pneumonia
- Respiratory Tract Infections
- Severe Acute Respiratory Syndrome
- Syndrome
- Tauopathies
- Virus Diseases
Recent trials (6)
- NCT04540185Lead sponsorPhase 3Nov 1, 2020
- NCT04452565Lead sponsorPhase 2/Phase 3Oct 15, 2020
- NCT04452565Study directorPhase 2/Phase 3Oct 15, 2020
- NCT04480333Lead sponsorPhase 1Sep 15, 2020
- NCT04480333Study directorPhase 1Sep 15, 2020
- NCT03538522Lead sponsorPhase 2Sep 15, 2018
Details
- Founded
- Melbourne, AU Aug 1, 2014
- Last known activity
- Nov 1, 2020